Literature DB >> 33617526

Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection.

Michael A Henson1.   

Abstract

Approximately 30% of patients who have Clostridioides difficile infection (CDI) will suffer at least one incident of reinfection. While the underlying causes of CDI recurrence are poorly understood, interactions between C. difficile and commensal gut bacteria are thought to play an important role. In this study, an in silico pipeline was used to process 16S rRNA gene amplicon sequence data of 225 stool samples from 93 CDI patients into sample-specific models of bacterial community metabolism. Clustered metabolite production rates generated from post-diagnosis samples generated a high Enterobacteriaceae abundance cluster containing disproportionately large numbers of recurrent samples and patients. This cluster was predicted to have significantly reduced capabilities for secondary bile acid synthesis but elevated capabilities for aromatic amino acid catabolism. When applied to 16S sequence data of 40 samples from fecal microbiota transplantation (FMT) patients suffering from recurrent CDI and their stool donors, the community modeling method generated a high Enterobacteriaceae abundance cluster with a disproportionate large number of pre-FMT samples. This cluster also was predicted to exhibit reduced secondary bile acid synthesis and elevated aromatic amino acid catabolism. Collectively, these in silico predictions suggest that Enterobacteriaceae may create a gut environment favorable for C. difficile spore germination and/or toxin synthesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33617526      PMCID: PMC7932513          DOI: 10.1371/journal.pcbi.1008782

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  92 in total

1.  A cluster separation measure.

Authors:  D L Davies; D W Bouldin
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  1979-02       Impact factor: 6.226

2.  Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Authors:  Elisabeth M Terveer; Monique J T Crobach; Ingrid M J G Sanders; Margreet C Vos; Cees M Verduin; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

3.  Prediction and quantification of bioactive microbiota metabolites in the mouse gut.

Authors:  Gautham V Sridharan; Kyungoh Choi; Cory Klemashevich; Charmian Wu; Darshan Prabakaran; Long Bin Pan; Shelby Steinmeyer; Carrie Mueller; Mona Yousofshahi; Robert C Alaniz; Kyongbum Lee; Arul Jayaraman
Journal:  Nat Commun       Date:  2014-11-20       Impact factor: 14.919

4.  Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

Authors:  Alexa R Weingarden; Chi Chen; Aleh Bobr; Dan Yao; Yuwei Lu; Valerie M Nelson; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

5.  Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism.

Authors:  Sture Karlsson; Lars G Burman; Thomas Åkerlund
Journal:  Microbiology       Date:  2008-11       Impact factor: 2.777

Review 6.  Burden of Clostridium difficile on the healthcare system.

Authors:  Erik R Dubberke; Margaret A Olsen
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

7.  Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.

Authors:  Alexa R Weingarden; Peter I Dosa; Erin DeWinter; Clifford J Steer; Megan K Shaughnessy; James R Johnson; Alexander Khoruts; Michael J Sadowsky
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

Review 8.  Elucidation of complexity and prediction of interactions in microbial communities.

Authors:  Cristal Zuñiga; Livia Zaramela; Karsten Zengler
Journal:  Microb Biotechnol       Date:  2017-09-19       Impact factor: 5.813

9.  Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection.

Authors:  Sophie Amrane; Marie Hocquart; Pamela Afouda; Edmond Kuete; Thi-Phuong-Thao Pham; Niokhor Dione; Issa Isaac Ngom; Camille Valles; Dipankar Bachar; Didier Raoult; Jean Christophe Lagier
Journal:  Sci Rep       Date:  2019-09-05       Impact factor: 4.379

Review 10.  Clostridium difficile drug pipeline: challenges in discovery and development of new agents.

Authors:  Angie M Jarrad; Tomislav Karoli; Mark A T Blaskovich; Dena Lyras; Matthew A Cooper
Journal:  J Med Chem       Date:  2015-03-30       Impact factor: 7.446

View more
  3 in total

Review 1.  Computational approaches to understanding Clostridioides difficile metabolism and virulence.

Authors:  Matthew L Jenior; Jason A Papin
Journal:  Curr Opin Microbiol       Date:  2021-11-25       Impact factor: 7.934

Review 2.  Viewing Bacterial Colonization through the Lens of Systems Biology.

Authors:  Madeline R Barron; Vincent B Young
Journal:  mSystems       Date:  2022-03-31       Impact factor: 7.324

3.  Metagenome-Scale Metabolic Network Suggests Folate Produced by Bifidobacterium longum Might Contribute to High-Fiber-Diet-Induced Weight Loss in a Prader-Willi Syndrome Child.

Authors:  Baoyu Xiang; Liping Zhao; Menghui Zhang
Journal:  Microorganisms       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.